Beacon Pointe Advisors, LLC Humacyte, Inc. Transaction History
Beacon Pointe Advisors, LLC
- $9.37 Billion
- Q2 2025
A detailed history of Beacon Pointe Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 36,000 shares of HUMA stock, worth $59,040. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,000
Previous 28,000
28.57%
Holding current value
$59,040
Previous $47,000
59.57%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HUMA
# of Institutions
166Shares Held
54.4MCall Options Held
1.1MPut Options Held
808K-
Black Rock Inc. New York, NY7.14MShares$11.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$11.5 Million0.0% of portfolio
-
State Street Corp Boston, MA4.39MShares$7.2 Million0.0% of portfolio
-
Center Book Partners LP Greenwich, CT3.43MShares$5.63 Million0.42% of portfolio
-
Geode Capital Management, LLC Boston, MA2.95MShares$4.84 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $169M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...